Status: awaiting_review. Rule: atlas-profile-2.0.
24 linked publications; not a count of independent studies.
Missing appraisal does not mean no evidence exists. Inspect the full profile and source relationships in the interactive Atlas.
Historical grade: WEAK (retained from 22 September 2026; not a completed profile 2.0 assessment).
Advanced imaging (DSC rCBV, DCE, diffusion, amino-acid PET) separates the two on average in cohorts
At the single-patient level thresholds are non-transferable across scanners/protocols; confirmation-scan waiting remains the de-facto standard
Premature therapy discontinuation vs. continuing ineffective toxic therapy; a core daily neuro-oncology decision
This is an educational research resource from Resonant Labs, not clinical advice. Atlas assessments are heuristic, not probabilities or formal GRADE ratings. Findings are summarized from the literature and may change as the field evolves.